Company Legal Name
Latest Valuation
Founded Year
Headquarters
CMR Surgical Limited develops and manufactures Versius, a next-generation surgical robot system designed for minimally invasive procedures across multiple medical specialties. Founded in 2014 and headquartered in Milton, United Kingdom, the company has positioned itself as a challenger to established surgical robotics platforms by offering a modular, portable system that provides hospitals with greater flexibility and cost-effectiveness. CMR Surgical has secured significant venture funding and achieved regulatory approvals in key markets including Europe and select international territories. The company continues expanding its clinical evidence base while pursuing broader market penetration and additional regulatory clearances globally.
Availability of information and platform features may vary by region and applicable requirements.
Eligibility and access may depend on user location, verification status, and applicable legal or regulatory requirements.
Additional platform details may be available after account creation, where applicable.
Identity, compliance, and other review steps may be required before access to certain materials or features.
Platform details, if applicable, should be reviewed in account materials before making any decision.
Any economic terms, if applicable, should be reviewed carefully in the relevant materials.
Private market interests may be illiquid, restricted, or difficult to transfer. Users should not assume that any secondary market will be available.
Valuations may reflect past financing rounds or other available information and may not represent a price at which any person can transact.
Company and sector risks may vary by business model, technology development, competition, regulation, and market conditions.
Operational, documentation, custody, or verification processes may involve limitations, delays, or dependencies.
Regulatory, tax, and legal requirements may change and may affect information availability, platform features, or user eligibility.
